Major depressive disorder (MDD) is the most common mental illness and the leading cause of disability worldwide. Electroconvulsive therapy (ECT) is the most effective treatment for MDD and the gold-standard therapy for treatment-resistant depression (TRD), yet it remains underutilized due to factors such as limited availability, stigma, and concerns about cognitive side effects. Ketamine has...
NeurologyApril 18, 2017D. Wheelwright, N. Dangayach, Stephen Griffiths et al.
Objective: We hypothesize that intra-ICU initiation of guided mindfulness meditation is feasible and will help prevent the development of anxiety and depression in good grade SAH patients. Background: Aneurysmal Subarachnoid Hemorrhage (SAH) has a case fatality rate of about 20%. Of all SAH patients, 40% are “good grade” defined as Hunt-Hess 1–2 with normal mental status whereas 60% are poor...
Electroconvulsive therapy (ECT) has long been regarded as the standard for quick antidepressant response. Recently, ketamine has been touted as an even faster antidepressant, notably in the report by Ghasemi et al. (2014) in which 18 patients (nine in each group) were given three intravenous ketamine infusions or three ECT treatments and followed for 1 week (Ghasemi et al., 2014). While the...